BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 7637321)

  • 1. Expression and prognostic significance of TGF-beta isotypes, latent TGF-beta 1 binding protein, TGF-beta type I and type II receptors, and endoglin in normal ovary and ovarian neoplasms.
    Henriksen R; Gobl A; Wilander E; Oberg K; Miyazono K; Funa K
    Lab Invest; 1995 Aug; 73(2):213-20. PubMed ID: 7637321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced expression of transforming growth factor-beta s and transforming growth factor-beta type II receptor in the synovial tissues of patients with rheumatoid arthritis.
    Taketazu F; Kato M; Gobl A; Ichijo H; ten Dijke P; Itoh J; Kyogoku M; Rönnelid J; Miyazono K; Heldin CH
    Lab Invest; 1994 May; 70(5):620-30. PubMed ID: 8196359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of transforming growth factor alpha gene expression in an ovarian surface epithelial cell line derived from a human carcinoma.
    Jindal SK; Ishii E; Letarte M; Vera S; Teerds KJ; Dorrington JH
    Biol Reprod; 1995 May; 52(5):1027-37. PubMed ID: 7626702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular characterization and in situ localization of murine endoglin reveal that it is a transforming growth factor-beta binding protein of endothelial and stromal cells.
    St-Jacques S; Cymerman U; Pece N; Letarte M
    Endocrinology; 1994 Jun; 134(6):2645-57. PubMed ID: 8194490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endoglin is a component of the transforming growth factor (TGF)-beta receptor complex of human pre-B leukemic cells.
    Zhang H; Shaw AR; Mak A; Letarte M
    J Immunol; 1996 Jan; 156(2):564-73. PubMed ID: 8543807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different expression of transforming growth factor beta 1 in pancreatic ductal adenocarcinoma and cystic neoplasms.
    Van Laethem JL; Resibois A; Rickaert F; Devière J; Gelin M; Cremer M; Robberecht P
    Pancreas; 1997 Jul; 15(1):41-7. PubMed ID: 9211491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal expression of Endoglin and its receptor complex (TGF-β1 and TGF-β receptor II) as early angiogenic switch indicator in premalignant lesions of the colon mucosa.
    Bellone G; Gramigni C; Vizio B; Mauri FA; Prati A; Solerio D; Dughera L; Ruffini E; Gasparri G; Camandona M
    Int J Oncol; 2010 Nov; 37(5):1153-65. PubMed ID: 20878063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endoglin is overexpressed after arterial injury and is required for transforming growth factor-beta-induced inhibition of smooth muscle cell migration.
    Ma X; Labinaz M; Goldstein J; Miller H; Keon WJ; Letarte M; O'Brien E
    Arterioscler Thromb Vasc Biol; 2000 Dec; 20(12):2546-52. PubMed ID: 11116051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased synovial expression of transforming growth factor (TGF)-beta receptor endoglin and TGF-beta 1 in rheumatoid arthritis: possible interactions in the pathogenesis of the disease.
    Szekanecz Z; Haines GK; Harlow LA; Shah MR; Fong TW; Fu R; Lin SJ; Rayan G; Koch AE
    Clin Immunol Immunopathol; 1995 Aug; 76(2):187-94. PubMed ID: 7614737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of transforming growth factor beta and transforming growth factor beta receptors on AIDS-associated Kaposi's sarcoma.
    Ciernik IF; Krayenbühl Ciernik BH; Cockerell CJ; Minna JD; Gazdar AF; Carbone DP
    Clin Cancer Res; 1995 Oct; 1(10):1119-24. PubMed ID: 9815902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of latent transforming growth factor-beta 1 (TGF-beta 1) binding protein 1 (LTBP-1) in association with TGF-beta 1 in ovarian carcinoma.
    Higashi T; Sasagawa T; Inoue M; Oka R; Shuangying L; Saijoh K
    Jpn J Cancer Res; 2001 May; 92(5):506-15. PubMed ID: 11376559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and expression of two forms of the human transforming growth factor-beta-binding protein endoglin with distinct cytoplasmic regions.
    Bellón T; Corbí A; Lastres P; Calés C; Cebrián M; Vera S; Cheifetz S; Massague J; Letarte M; Bernabéu C
    Eur J Immunol; 1993 Sep; 23(9):2340-5. PubMed ID: 8370410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the expression pattern of the latent transforming growth factor beta binding protein isoforms in normal and diseased human liver reveals a new splice variant missing the proteinase-sensitive hinge region.
    Michel K; Roth S; Trautwein C; Gong W; Flemming P; Gressner AM
    Hepatology; 1998 Jun; 27(6):1592-9. PubMed ID: 9620332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor-beta expression in prostate neoplasia.
    Cardillo MR; Petrangeli E; Perracchio L; Salvatori L; Ravenna L; Di Silverio F
    Anal Quant Cytol Histol; 2000 Feb; 22(1):1-10. PubMed ID: 10696454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1,25-Dihydroxyvitamin D3 enhances the expression of transforming growth factor beta 1 and its latent form binding protein in cultured breast carcinoma cells.
    Koli K; Keski-Oja J
    Cancer Res; 1995 Apr; 55(7):1540-6. PubMed ID: 7882362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endoglin forms a heteromeric complex with the signaling receptors for transforming growth factor-beta.
    Yamashita H; Ichijo H; Grimsby S; Morén A; ten Dijke P; Miyazono K
    J Biol Chem; 1994 Jan; 269(3):1995-2001. PubMed ID: 8294451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endocervical cancer is associated with an increase in the ligands and receptors for transforming growth factor-beta and a contrasting decrease in p27(Kip1).
    Farley J; Gray K; Nycum L; Prentice M; Birrer MJ; Jakowlew SB
    Gynecol Oncol; 2000 Aug; 78(2):113-22. PubMed ID: 10926789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of the latent transforming growth factor beta binding protein in malignant, but not benign prostatic tissue.
    Eklöv S; Funa K; Nordgren H; Olofsson A; Kanzaki T; Miyazono K; Nilsson S
    Cancer Res; 1993 Jul; 53(13):3193-7. PubMed ID: 7686449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endoglin (CD105) is expressed on immature blood vessels and is a marker for survival in prostate cancer.
    Wikström P; Lissbrant IF; Stattin P; Egevad L; Bergh A
    Prostate; 2002 Jun; 51(4):268-75. PubMed ID: 11987155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TGF-{beta} signaling of human T cells is modulated by the ancillary TGF-{beta} receptor endoglin.
    Schmidt-Weber CB; Letarte M; Kunzmann S; Rückert B; Bernabéu C; Blaser K
    Int Immunol; 2005 Jul; 17(7):921-30. PubMed ID: 15967783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.